SCHEMBL5143416

SCHEMBL5143416

[CH2]COCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21

nearest known ligand 0.84

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.84
ERBB2 P04626 20/20 0.84
ERBB3 P21860 15/20 0.84
ERBB4 Q15303 15/20 0.84
BMPR1B O00238 1/20 0.70
EPHB6 O15197 1/20 0.70
LCK P06239 1/20 0.70
LYN P07948 1/20 0.70
MET P08581 1/20 0.70
CSK P41240 1/20 0.70
MAP2K1 Q02750 1/20 0.70
MAP2K5 Q13163 1/20 0.70
AURKB Q96GD4 1/20 0.70
NLK Q9UBE8 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2747629 0.93 EGFR (0.85) EGFRERBB2ERBB3ERBB4BMPR1B
SCHEMBL4544794 0.91 EGFR (0.85) EGFRERBB2ERBB3ERBB4BMPR1B
SCHEMBL986656 0.91 EGFR (1.00) EGFRERBB2ERBB3ERBB4BMPR1B
SCHEMBL4544721 0.91 EGFR (0.84) EGFRERBB2ERBB3ERBB4BMPR1B
Hydrochloric Acid SCHEMBL2748215 0.91 EGFR (0.84) EGFRERBB2ERBB3ERBB4BMPR1B
Hydrochloric Acid SCHEMBL2749159 0.90 EGFR (0.83) EGFRERBB2ERBB3ERBB4BMPR1B
SCHEMBL3127092 0.90 EGFR (0.85) EGFRERBB2ERBB3ERBB4BMPR1B
SCHEMBL2747535 0.90 EGFR (0.85) EGFRERBB2ERBB3ERBB4BMPR1B
SCHEMBL2749566 0.90 EGFR (1.00) EGFRERBB2ERBB3ERBB4BMPR1B
SCHEMBL2747461 0.89 EGFR (0.82) EGFRERBB2ERBB3ERBB4BMPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1752457-B1 FUSED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL (JP) 2014-03-19 EP disclosed
EP-1752457-A1 FUSED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-02-14 EP disclosed